Pseudomyxoma peritonei refers to syndrome of progressive intraperitoneal accumulation of mucinous ascites related to a mucin-producing neoplasm. It is most commonly caused by a mucinous tumor of the appendix 10.
Much less commonly, mucinous tumors of colon, rectum, stomach, pancreas , and urachus 9,10,13 are implicated. There is some ongoing contention as to whether primary ovarian tumors are a frequent source in their own right, or whether in these cases the appendix is the primary site and the ovarian lesion is metastatic 2,3.
The terminology regarding pseudomyxoma peritonei can be a bit confusing, and continues to evolve over time. In 2016, a consensus group, the Peritoneal Surface Oncology Group International, published guidelines for classification for mucinous appendiceal tumors and associated peritoneal disease (see appendiceal mucinous neoplasm article).
An "appendiceal mucocele" is a descriptive term which refers to the appearance of a dilated mucin-filled appendix. Although this is the imaging manifestation of appendiceal mucinous tumors, appendiceal mucoceles may also represent non-neoplastic etiologies such as mucosal hyperplasia or retention cyst related to luminal obstruction 14.
Pseudomyxoma peritonei (of appendiceal origin) is due to invasion or rupture of the appendix from a mucin-secreting appendiceal tumor.
It is important to understand that pseudomyxoma peritonei represents a spectrum of disease. The characteristic mucinous ascites is composed of acellular mucin and a variable amount of neoplastic epithelial cells. Indeed, pseudomyxoma peritonei is not a histologic diagnosis - the label merely implies grossly mucinous intraperitoneal deposits 15.
The remarkable feature of pseudomyxoma peritonei is that this neoplastic, progressive process often arises from a seemingly benign or well-differentiated primary tumor 3. However once there is intraperitoneal spread, the mucinous deposits tend to follow routes of normal peritoneal fluid flow, spreading along the pelvis, paracolic gutters, liver capsule, and omentum, while often sparing mobiel organs, e.g. small bowel 13, 14.
Pseudomyxoma peritonei may be divided into two pathological subtypes which have etiological and prognostic significance 4:
- a peritoneal neoplasm composed largely of mucin associated with fibrosis with minimal cytological atypia and mitoses
- the primary tumor is generally an adenoma
peritoneal mucinous carcinoma
- characterized by proliferative epithelium, glands, nests, or individual cells with marked cytologic atypia
- the primary is a mucinous adenocarcinoma
Not all cases fit neatly into these categories, and many patients have intermediate or discordant features.
However, a long term follow-up study 4 of 109 patients found 5-year survival rates were markedly different: 75% for the adenomucinosis group and 14% for the mucinous carcinoma group. The intermediate/discordant group 5 year survival was 50%.
Pseudomyxoma peritonei is characterized by loculated collections of fluid which accumulate along peritoneal surfaces, classically resulting in a scalloped appearance of coated abdominal organs and omental caking. An appendiceal mucocele (representing a mucinous appendiceal tumor) may be visualized.
- since appendiceal tumors are most common etiology, early peritoneal disease may be limited to the right lower quadrant abdomen 15
- deposits tend to localize to site of physiologic lymphatic absorption of ascites (omentum, underneath right hemidiaphragm), and dependent areas (e.g. paracolic gutters, right retrohepatic space, lower pelvis) 14
- deposits tend to spare the more mobile small bowel until later in disease, when it eventually causes bowel obstruction 14
May show evidence of ascites with centrally displaced small bowel loops and scattered punctate or curvilinear calcifications.
- echogenic peritoneal masses or ascites with echogenic particles which (unlike other forms of particulate ascites such as hemoperitoneum or pus in the peritoneum) do not move 6
- small bowel loops displaced medially
- may show scalloping of the liver, spleen and at times other organs
- simple or loculated low attenuation fluid throughout intraperitoneal spaces, omentum, and mesentery 14
- scalloping of visceral surfaces, particularly the liver 5
- often with scattered (curvilinear or punctate) calcifications 5
- tends to remain localized to peritoneal cavity - thoracic and nodal lesions metastases uncommon
Reported signal characteristics of the collections include 8
- T1: typically low signal
- T2: typically high signal
- T1 C+ (Gd): may show enhancement 12
Treatment and prognosis
This is a progressive and often fatal disease. Recurrent bowel obstructions are commonly due to the fibrosis and adhesions in advanced disease 13.
Treatment is surgical debulking, followed by infusion of intraperitoneal chemotherapy. Aggressive surgical treatment has been considered based on the calculation of the peritoneal cancer index (PCI), which is a prognostic indicator based on the amount of tumor found at laparoscopy. This index has been performed using CT or MRI 13.
General imaging differential considerations include:
- 1. Brant WE, Helms CA. Fundamentals of diagnostic radiology. Lippincott Williams & Wilkins. (2007) ISBN:0781761352. Read it at Google Books - Find it at Amazon
- 2. Federle MP, Jeffrey RB, Woodward PJ et-al. Diagnostic Imaging: Abdomen, Published by Amirsys®. Lippincott Williams & Wilkins. (2009) ISBN:1931884714. Read it at Google Books - Find it at Amazon
- 3. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch. Pathol. Lab. Med. 2010;134 (6): 864-70. Arch. Pathol. Lab. Med. (link) - Pubmed citation
- 4. Ronnett BM, Yan H, Kurman RJ et-al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92 (1): 85-91. Cancer (link) - Pubmed citation
- 5. Yoo E, Kim JH, Kim MJ et-al. Greater and lesser omenta: normal anatomy and pathologic processes. Radiographics. 27 (3): 707-20. doi:10.1148/rg.273065085 - Pubmed citation
- 6. Hanbidge AE, Lynch D, Wilson SR. US of the peritoneum. Radiographics. 23 (3): 663-84. doi:10.1148/rg.233025712 - Pubmed citation
- 7. Ros PR, Mortele KJ. CT and MRI of the abdomen and pelvis, a teaching file. Lippincott Williams & Wilkins. (2006) ISBN:0781772370. Read it at Google Books - Find it at Amazon
- 8. Buy JN, Malbec L, Ghossain MA et-al. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol. 1989;9 (2): 115-8. - Pubmed citation
- 9. Sugiyama K, Ito N. Mucinous cystadenocarcinoma of the urachus associated with pseudomyxoma peritonei with emphasis on MR findings. Magn Reson Med Sci. 2009;8 (2): 85-9. Magn Reson Med Sci (link) - Pubmed citation
- 10. Takeuchi M, Matsuzaki K, Yoshida S et-al. Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei. Acta Radiol. 2004;45 (3): 348-50. Acta Radiol (link) - Pubmed citation
- 11. Semelka RC. Abdominal-Pelvic MRI. Wiley-Blackwell. (2010) ISBN:0470487755. Read it at Google Books - Find it at Amazon
- 12. Eurorad teaching files : Case 1239
- 13. Leonards LM, Pahwa A, Patel MK, Petersen J, Nguyen MJ, Jude CM. Neoplasms of the Appendix: Pictorial Review with Clinical and Pathologic Correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 37 (4): 1059-1083. doi:10.1148/rg.2017160150 - Pubmed
- 14. Bartlett DJ, Thacker PG, Grotz TE, Graham RP, Fletcher JG et al. Mucinous appendiceal neoplasms: classification, imaging, and HIPEC. (2019) Abdominal Radiology. doi:10.1007/s00261-018-01888-y - Pubmed
- 15. Legué LM, Creemers GJ, de Hingh IHJT, Lemmens VEPP, Huysentruyt CJ. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei. (2018) Clinical colorectal cancer. doi:10.1016/j.clcc.2018.11.007 - Pubmed